Wright Investors Service’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.84M Sell
56,272
-981
-2% -$137K 2.47% 8
2025
Q4
$7.03M Buy
57,253
+629
+1% +$76.4K 2.11% 9
2025
Q3
$6.29M Buy
56,624
+5,677
+11% +$645K 1.82% 10
2025
Q2
$5.65M Buy
50,947
+282
+0.6% +$30K 1.71% 13
2025
Q1
$5.68M Buy
50,665
+2,484
+5% +$256K 1.88% 14
2024
Q4
$4.45M Sell
48,181
-15,942
-25% -$1.44M 1.45% 21
2024
Q3
$5.38M Buy
64,123
+10,631
+20% +$811K 1.41% 19
2024
Q2
$3.67M Buy
53,492
+28,218
+112% +$1.88M 0.97% 26
2024
Q1
$1.85M Buy
25,274
+42
+0.2% +$3.23K 0.47% 67
2023
Q4
$2.04M Sell
25,232
-1,167
-4% -$90.8K 0.58% 60
2023
Q3
$1.98M Sell
26,399
-233
-0.9% -$17.9K 0.57% 57
2023
Q2
$2.05M Buy
26,632
+3,552
+15% +$283K 0.58% 58
2023
Q1
$1.91M Buy
23,080
+1,013
+5% +$83.9K 0.54% 67
2022
Q4
$1.89M Buy
22,067
+1,160
+6% +$91.9K 0.54% 70
2022
Q3
$1.29M Buy
20,907
+226
+1% +$14.3K 0.41% 82
2022
Q2
$1.28M Buy
20,681
+11,421
+123% +$707K 0.37% 85
2022
Q1
$551K Buy
9,260
+81
+0.9% +$5.18K 0.14% 126
2021
Q4
$666K Buy
9,179
+435
+5% +$30K 0.17% 118
2021
Q3
$611K Buy
8,744
+209
+2% +$14.7K 0.17% 120
2021
Q2
$588K Buy
8,535
+992
+13% +$66.2K 0.16% 122
2021
Q1
$488K Buy
7,543
+108
+1% +$6.96K 0.15% 132
2020
Q4
$433K Sell
7,435
-14,318
-66% -$864K 0.15% 130
2020
Q3
$1.38M Buy
21,753
+534
+3% +$37K 0.49% 63
2020
Q2
$1.63M Sell
21,219
-412
-2% -$31.6K 0.63% 49
2020
Q1
$1.62M Buy
21,631
+147
+0.7% +$10.2K 0.7% 43
2019
Q4
$1.4M Sell
21,484
-12,749
-37% -$830K 0.48% 64
2019
Q3
$2.17M Sell
34,233
-10,727
-24% -$701K 0.78% 41
2019
Q2
$3.04M Buy
44,960
+32,110
+250% +$2.11M 1.16% 22
2019
Q1
$835K Buy
12,850
+258
+2% +$17.1K 0.34% 75
2018
Q4
$788K Buy
12,592
+1,471
+13% +$103K 0.34% 79
2018
Q3
$859K Sell
11,121
-128
-1% -$9.67K 0.31% 78
2018
Q2
$797K Sell
11,249
-31,986
-74% -$2.26M 0.32% 84
2018
Q1
$3.26M Sell
43,235
-11
-0% -$874 1.12% 25
2017
Q4
$3.1M Sell
43,246
-2,306
-5% -$175K 1.04% 29
2017
Q3
$3.69M Buy
45,552
+8,406
+23% +$643K 1.34% 20
2017
Q2
$2.63M Buy
37,146
+4,310
+13% +$287K 0.99% 27
2017
Q1
$2.23M Buy
32,836
+5,611
+21% +$395K 0.9% 28
2016
Q4
$1.95M Sell
27,225
-1,160
-4% -$86.2K 0.84% 28
2016
Q3
$2.25M Buy
28,385
+7,080
+33% +$575K 0.94% 32
2016
Q2
$1.78M Sell
21,305
-13,365
-39% -$1.19M 0.73% 42
2016
Q1
$3.19M Buy
34,670
+7,045
+26% +$635K 1.26% 17
2015
Q4
$2.79M Buy
27,625
+4,110
+17% +$428K 1.03% 16
2015
Q3
$2.31M Buy
23,515
+10,921
+87% +$1.21M 1.04% 22
2015
Q2
$1.48M Sell
12,594
-1,743
-12% -$190K 0.7% 40
2015
Q1
$1.41M Buy
14,337
+4,618
+48% +$469K 0.68% 40
2014
Q4
$916K Buy
9,719
+2,098
+28% +$217K 0.45% 70
2014
Q3
$811K Buy
7,621
+1,191
+19% +$117K 0.4% 78
2014
Q2
$533K Buy
6,430
+96
+2% +$7.47K 0.24% 131
2014
Q1
$449K Sell
6,334
-4,775
-43% -$374K 0.2% 151
2013
Q4
$834K Sell
11,109
-8,895
-44% -$619K 0.37% 84
2013
Q3
$1.26M Sell
20,004
-4,736
-19% -$283K 0.57% 53
2013
Q2
$1.27M Buy
+24,740
New +$1.29M 0.6% 46

Other funds holding GILD

Wright Investors Service's GILD Position: Q1 2026 in Review

Wright Investors Service reduced its Gilead Sciences (GILD) stake by 1.7% in Q1 2026, selling an estimated $137K and leaving 56,272 shares worth $7.84M. The position accounts for 2.47% of the portfolio, ranked #8.

Wright Investors Service first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Wright Investors Service held 56,272 shares of Gilead Sciences worth $7.84M as of Q1 2026.
  • Wright Investors Service sold 981 Gilead Sciences shares in Q1 2026, an estimated $137K.
  • Gilead Sciences made up 2.47% of Wright Investors Service's portfolio in Q1 2026, its #8 holding.
  • Wright Investors Service first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Wright Investors Service's 13F filing for Q1 2026, filed 29 Apr 2026.